Provided by Tiger Fintech (Singapore) Pte. Ltd.

Monte Rosa Therapeutics

5.33
+0.520010.81%
Post-market: 5.330.00000.00%16:20 EDT
Volume:673.82K
Turnover:3.55M
Market Cap:327.85M
PE:-5.42
High:5.40
Open:4.98
Low:4.98
Close:4.81
Loading ...
May 11, 2022

Major Issues Report

8-K - Current report
Mar 29, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 29, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 29, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 10, 2022

Major Issues Report

8-K - Current report
Dec 15, 2021

Major Issues Report

8-K - Current report
Nov 12, 2021

Major Issues Report

8-K - Current report
Nov 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2021

Major Issues Report

8-K - Current report
Aug 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 12, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jul 08, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jul 08, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 28, 2021

Major Issues Report

8-K - Current report
Jun 25, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jun 21, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jun 21, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jun 21, 2021

Correspondence

CORRESP [Cover] - Correspondence